At six, Lucas faced a rare brain tumor, casting a grim shadow over his future. Now 13, he stands as a beacon of hope, having conquered brainstem glioma, a typically fatal cancer.
Dr. Jacques Grill, from Paris’s Gustave Roussy Cancer Center, lauds Lucas’s resilience, citing his exceptional response to the drug everolimus. Through the BIOMEDE trial in France, Lucas’s tumor vanished entirely, an unprecedented feat.
Researchers are intrigued by Lucas’s case, delving into genetic anomalies for insights. However, they caution that viable treatments are still years away, underscoring the need for continued research and clinical trials.
Author :lezizmutfagim.net
Pages: 1 2